Volume | 50 793 |
|
|||||
Actualités | - | ||||||
Maximum Haut | 1,99 | Bas Haut |
|||||
Minimum Bas | 1,93 |
Nom Action | Symbole Action | Marché | Type |
---|---|---|---|
ProQR Therapeutics NV | PRQR | NASDAQ | Action ordinaire |
Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
---|---|---|---|---|
1,95 | 1,93 | 1,99 | 1,94 | 1,96 |
Transactions Totales | Volume échangé | VWAP | Volume Financier | Volume en moyenne | Sur 52 semaines |
---|---|---|---|---|---|
560 | 50 793 | US$ 1,95 | US$ 99 197 | - | 1,11 - 3,29 |
Dernière Transaction | Type | Quantités échangées | Prix transaction | Devise |
---|---|---|---|---|
22:03:51 | formt | 973 | US$ 1,98 | USD |
Bilan Comptable
Capitalisation Boursière | Actions en Circulation | Float | Chiffre d'affaires | Bénéfice/Perte | BPA | Ratio Cours sur Bénéfices |
---|---|---|---|---|---|---|
157,83M | 81,35M | - | 6,59M | -28,12M | -0,35 | - |
Short Interest | Dividendes Par Action | Rendement du Dividende | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
plus d’informations financières »
Actualités Action ProQR Therapeutics NV
Date | Heure | Source | Titre |
---|---|---|---|
15/2/2024 | 13:46 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
14/2/2024 | 12:08 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
09/2/2024 | 12:37 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
19/1/2024 | 13:08 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
05/1/2024 | 13:08 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
07/11/2023 | 16:00 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
27/9/2023 | 13:06 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
14/9/2023 | 23:20 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial.. |
03/8/2023 | 13:15 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
01/8/2023 | 13:15 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
Forum Action ProQR Therapeutics NV
Aucune Discussion TrouvéeAjouter une Discussion
Historiques ProQR Therapeutics NV
Période | Ouver. | Haut | Bas | VWAP | Moyenne Vol. Quot. | Variation | % |
---|---|---|---|---|---|---|---|
1 semaine | 1,90 | 2,12 | 1,84 | 1,99 | 141 591 | 0,04 | 2,11% |
1 mois | 2,26 | 2,46 | 1,81 | 2,09 | 165 543 | -0,32 | -14,16% |
3 mois | 2,17 | 2,70 | 1,81 | 2,13 | 207 739 | -0,23 | -10,60% |
6 mois | 1,23 | 3,29 | 1,11 | 2,05 | 261 652 | 0,71 | 57,72% |
1 an | 2,24 | 3,29 | 1,11 | 1,87 | 264 241 | -0,30 | -13,39% |
3 ans | 6,18 | 9,09 | 0,53 | 2,83 | 809 861 | -4,24 | -68,61% |
5 ans | 11,23 | 13,28 | 0,53 | 4,52 | 744 825 | -9,29 | -82,72% |